Multiresistant bacteria as a hospital epidemic problem

References

• Finland M. Changing patterns of resistance of certain common pathogenic bacteria to antimicrobial agents. N Engl J Med 1955; 252: 570–80
   PubMedGoogle Scholar
• Neu H C. The crisis in antibiotic resistance. Science 1992; 257: 1064–73
   PubMed Web of Science ®Google Scholar
• Emori T G, Gaynes R P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428–42
   PubMed Web of Science ®Google Scholar
• Barber M. Methicillin-resistant staphylococci. J Clin Pathol 1961; 14: 385–93
   PubMed Web of Science ®Google Scholar
• Jacoby G A, Archer G L. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991; 324: 601–12
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670–3
   PubMed Web of Science ®Google Scholar
• Haley R W, Hightower A W, Khabbaz R F, et al. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med 1982; 97: 297–308
   PubMed Web of Science ®Google Scholar
• Thompson R L, Cabezudo I, Wenzel R P. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97: 309–17
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control (CDC). Methicillin-resistant Staphylococcus aureus. MMWR Morb Mortal Wkly Rep 1981; 30: 140–7
   PubMedGoogle Scholar
• Storch G A, Radcliff J L, Meyer P L, Hinrichs J H. Methicillin-resistant Staphylococcus aureus in a nursing home. Infect Control 1987; 8: 24–9
   PubMedGoogle Scholar
• Kaufmann C A, Bradley S F, Terpenning M S. Methicillin-resistant Staphylococcus aureus in long-term care facilities. Infect Control Hasp Epidemiol 1990; 11: 600–3
   PubMedGoogle Scholar
• Levine D P, Cushing R D, Jui J, et al. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med 1982; 97: 330–8
   PubMed Web of Science ®Google Scholar
• Mulligan M E, Murray-Leisure K, Ribner B S, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993; 94: 313–28
   PubMed Web of Science ®Google Scholar
• Saravolatz L D, Pohlod D J, Arking L M. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 1982; 97: 325–9
   PubMed Web of Science ®Google Scholar
• Speller D CE, Johnson A P, James D, Marples R R, Charlett A, George R C. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989–95. Lancet 1997; 350: 323–5
   PubMed Web of Science ®Google Scholar
• Vincent J L, Bihari D J, Suter P M, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639–44
   PubMed Web of Science ®Google Scholar
• Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl V T, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50–5
   PubMed Web of Science ®Google Scholar
• Frenay H M, Vandenbroucke-Grauls C MJE, Molkenboer M J, et al. Long-term carriage, and transmission of methicillin-resistant Staphylococcus aureus after discharge from hospital. Infect Control 1992; 22: 207–15
   Google Scholar
• Crossley K, Landesman B, Zaske D. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. II. Epidemiologic studies. J Infect Dis 1979; 139: 280–7
   PubMedGoogle Scholar
• Peacock J E, Marsik F J, Wenzel R P. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 1980; 93: 526–32
   PubMed Web of Science ®Google Scholar
• Boyce J M, Opal S M, Potter-Bynoe G, et al. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis 1993; 17: 496–504
   PubMed Web of Science ®Google Scholar
• Boyce J M, White R L, Causey W A, Lockwood W R. Burn units as a source of methicillin resistant Staphylococcus aureus infections. JAMA 1983; 249: 2803–7
   PubMedGoogle Scholar
• Rutala W A, Katz E BS, Sheretz R J, Sarubbi F A. Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit. J Clin Microbiol 1983; 18: 683–8
   PubMedGoogle Scholar
• Farrington M, Ling J, Ling T, French G L. Outbreaks of infection with methicillin-resistant Staphylococcus aureus on neonatal and burns units of a new hospital. Epidemiol Infect 1990; 105: 215–28
   PubMed Web of Science ®Google Scholar
• Jernigan J A, Titus M G, Groschel D HM, Getchell-White S I, Farr B M. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996; 143: 496–504
   PubMedGoogle Scholar
• Haley R W, Cushion N B, Tenover F C, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995; 171: 614–24
   PubMedGoogle Scholar
• Doebbeling B N, Breneman D L, Neu H C, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. Clin Infect Dis 1993; 17: 466–74
   PubMed Web of Science ®Google Scholar
• Dawson S J, Finn L F, McCulloch J E, et al. Mupirocin-resistant MRSA. J Hosp Infect 1994; 28: 75–8
   PubMedGoogle Scholar
• Marples R R, Speller D CE. Cookson. Prevalence of mupirocin resistance in Staphylococcus aureus. J Hosp Infect 1995; 29: 153–61
   PubMed Web of Science ®Google Scholar
• Murray B E. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3: 46–65
   PubMed Web of Science ®Google Scholar
• Edmond M B, Ober J F, Dawson J D, Weinbaum D L, Wenzel R P. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996; 23: 1234–9
   PubMed Web of Science ®Google Scholar
• Maki D G, Agger W A. Enterococcal bacteremia: clinical features, the risk of endocarditis, and managment. Medicine 1988; 67: 248–69
   PubMed Web of Science ®Google Scholar
• Moellering R C. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 1992; 14: 1173–8
   PubMed Web of Science ®Google Scholar
• Murray B E, Mederski-Samoraj B. Transferable P-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest 1983; 72: 1168–71
   PubMedGoogle Scholar
• Uttley A HC, Collins C H, Naidoo J, George R C. Vancomycin-resistant enterococci. Lancet 1988; i: 57–8
   Google Scholar
• Uttley A H, George R C, Naidoo J, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989; 103: 173–81
   PubMed Web of Science ®Google Scholar
• Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157–61
   PubMed Web of Science ®Google Scholar
• Noble W C, Virani A, Cree R. Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195–8
   Web of Science ®Google Scholar
• Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997; 24: 545–56
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control (CDC). Nosocomial enterococci resistant to vancomycin - United States, 1989–1993. MMWR Morb Mortal Wkly Rep 1993; 42: 597–9
   PubMedGoogle Scholar
• Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16: 750–5
   PubMed Web of Science ®Google Scholar
• Montecalvo M A, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38: 1363–7
   PubMed Web of Science ®Google Scholar
• Boyce J M, Opal S M, Chow J W, et al. Outbreak of multi-drug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32: 1148–53
   PubMed Web of Science ®Google Scholar
• Jordens J Z, Bates J, Griffiths D T. Eaecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. Antimicrob Chemother 1994; 34: 515–28
   Google Scholar
• Edmond M B, Ober J F, Weinbaum D L, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126–33
   PubMed Web of Science ®Google Scholar
• Moreno F, Grota P, Crisp C. et al. Clinical and molecular epidemiology of vancomycin-resistant enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995; 21: 1234–7
   PubMedGoogle Scholar
• Biavasco F, Miele A, Vignaroli C, Manso E, Lupidi R, Varaldo P E. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis. Microb Drug Resist 1996; 2: 231–7
   PubMedGoogle Scholar
• Pegues D A, Pegues C F, Hibberd P L, Ford D S, Hooper D C. Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol 1997; 35: 1565–70
   PubMedGoogle Scholar
• Dunne W M, Wang W. Clonal dissemination and colony morphotype variation of vancomycin-resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan. J Clin Microbiol 1997; 35: 388–92
   PubMedGoogle Scholar
• Slaughter S, Hayden M K, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996; 125: 448–56
   PubMedGoogle Scholar
• Morris J G, Jr, Shay D K, Hebden J N, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a University Medical Center. Ann Intern Med 1995; 123: 250–9
   PubMed Web of Science ®Google Scholar
• Bonten M, Hayden M K, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348: 1615–9
   PubMed Web of Science ®Google Scholar
• Manso E, de Sio G, Biavasco F, Varaldo P E, Sambo G, Maffei C. Vancomycin-resistant enterococci. Lancet 1993; 342: 616–7
   PubMedGoogle Scholar
• Livornese L L, Jr, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117: 112–6
   PubMed Web of Science ®Google Scholar
• Bonten M JM, Hayden M K, Nathan C, Rice T W, Weinstcin R A. Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis, in press
   Google Scholar
• Montecalvo M A, de Lencastre H, Carraher M, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995; 16: 680–5
   PubMed Web of Science ®Google Scholar
• Bonten M JM, Slaughter S, Ambergen A W, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med, in press
   Google Scholar
• Rhinehart E, Smith N E, Wennerstein C, et al. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med 1990; 323: 1814–8
   PubMed Web of Science ®Google Scholar
• Elizaga M L, Beezhold D, Hayden M K, et al (1996) The prevalence of colonization with vancomycin-resistant enterococci (VRE) among hospitalized residents of long-term care facilities (LTCF) (abstract) 352. Abstracts of the Infectious Diseases Society of America (IDSA) 34th Annual Meeting. Sept 18–20, 1996. New Orleans, LA, 101
   Google Scholar
• Brown D FJ, Courvalin P, Group T EGR (1996) European Glyco-peptide Susceptibility Survey: susceptibility of Enterococcus app to teicoplanin and vancomycin. Proceedings of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, Sept 15–18, 1996, 85, abstract E26
   Google Scholar
• Gordts B, van Landuyt H, Ieven M, Vandamme P, Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tract of hospitalized patients. J Clin Microbiol 1995; 33: 2842–6
   PubMed Web of Science ®Google Scholar
• van der Auwera P, Pensart N, Korten V, Murray B E, Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996; 173: 1129–36
   PubMed Web of Science ®Google Scholar
• Coque T M, Tomayko J F, Ricke S C, Okhuysen P C, Murray B E. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996; 40: 2605–9
   PubMed Web of Science ®Google Scholar
• Witte W, Klare I. Glycopeptide-resistant Enterococcus faecium outside hospitals: a commentary. Microb Drug Resist 1995; 1: 259–63
   PubMedGoogle Scholar
• van den Bogaard A E, Jensen L B, Stobberingh E E. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 1997; 337: 1558–9
   PubMedGoogle Scholar
• Bergmans D CJJ, Bonten M JM, Gaillard C A, et al. Indications for antibiotic use in 1CU patients: a one-year prospective surveillance. J Antimicrob Chemother 1997; 39: 527–35
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control (CDC). Preventing the spread of vancomycin resistance. Report from the Hospital Infection Control Practices Advisory Committee. Federal Register 1994; 59: 25758–63
   PubMedGoogle Scholar
• Quale J, Landman D, Saurina G, Atwood E, Ditorc V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996; 23: 1020–5
   PubMed Web of Science ®Google Scholar
• Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315–7
   PubMed Web of Science ®Google Scholar
• Payne D J, Marriott M S, Amyes S GB. Mutants of the TEM-1 P-lactamase conferring resistance to ceftazidime. J Antimicrob Chemother 1989; 24: 103–10
   PubMedGoogle Scholar
• Bush K, Jacoby G. Nomenclature of TEM β-lactamases. J Antimicrob Chemother 1997; 39: 1–3
   PubMed Web of Science ®Google Scholar
• Medeiros A A. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997; 24(Suppl 1)SI9–45
   Google Scholar
• Paterson D L, Ko W C, Mohapatra S, et al (1997) Klebsiella pneumoniae bacteremia: impact of extended spectrum beta-lactamases production in a global study of 216 patients (abstract). Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, Sept, 15–181996. American Society for Microbiology, Washington, DC, 328–J-210
   Google Scholar
• Itokazu G S, Quinn J P, Bell-Dixon C, Kahan F M, Weinstein R A. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 1996; 23: 779–84
   PubMed Web of Science ®Google Scholar
• Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; ii: 302–6
   Google Scholar
• Jarlier V, Nicolas M H, Fournier G, Philippon A. Extended broad-spectrum P-lactamases conferring transferable resistance to newer p-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867–78
   PubMedGoogle Scholar
• Sirot J, Chanal C, Petit A, Sirot D, Labia R, Gerbaud G. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Rev Infect Dis 1988; 10: 850–9
   PubMedGoogle Scholar
• Arlet G, Sanson-le Pors M J, Rouveau M, et al. Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. Eur J Clin Microbiol Infect Dis 1990; 9: 797–803
   PubMedGoogle Scholar
• Papanicolaou G A, Medeiros A A, Jacoby G A. Novel plasmid-mediated P-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990; 34: 2200–9
   PubMed Web of Science ®Google Scholar
• Rice L B, Willey S H, Papanicolaou G A, et al. Outbreak of ceftazidime resistance caused by extended-spectrum p-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990; 34: 2193–9
   PubMed Web of Science ®Google Scholar
• de Champs C, Rouby D, Guelon D, et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 1991; 18: 5–13
   PubMed Web of Science ®Google Scholar
• Naumovski L, Quinn J P, Miyashiro D, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992; 36: 1991–6
   PubMed Web of Science ®Google Scholar
• Coovadia Y M, Johnson A P, Bhana R H, Hutchinson G R, George R C, Hafferjee I E. Multiresitant Klebsiella pneumoniae in a neonatal nursery: the importance of maintainance of infection control policies and procedures in the prevention of outbreaks. J Hosp Infect 1992; 22: 197–205
   PubMed Web of Science ®Google Scholar
• Bauernfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients. Infection 1993; 21: 18–22
   PubMed Web of Science ®Google Scholar
• Meyer K S, Urban C, Eagan J A, Berger B J, Rahal J J. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119: 353–8
   PubMed Web of Science ®Google Scholar
• Prodinger W M, Fille M, Bauernfeind A, et al. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 β-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996; 34: 564–8
   PubMed Web of Science ®Google Scholar
• Hobson R P, MacKenzie F M, Gould I M. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 1996; 33: 249–62
   PubMedGoogle Scholar
• Schiappa D A, Hayden M K, Matushek M G, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996; 174: 529–36
   PubMed Web of Science ®Google Scholar
• Lucet J-C, Chevret S, Deere D, et al. Outbreak of multiply resistant Enterobacteriaceae in an Intensive Care Unit: Epidemiology and risk factors for acquisition. Clin Infect Dis 1996; 22: 430–6
   PubMed Web of Science ®Google Scholar
• Coudron P E, Moland E S, Sanders C. Occurrence and detection of extended-spectrum β-latamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol 1997; 35: 2593–7
   PubMed Web of Science ®Google Scholar
• D'Agata E, Venkataraman L, De Girolami P, Samore M. Molecular epidemiology of acquisition of ceftazidime-resistant Gram-negative bacilli in a nonoutbreak setting. J Clin Microbiol 1997; 35: 2602–5
   PubMedGoogle Scholar
• French G L, Shannon K P, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 1996; 34: 358–63
   PubMed Web of Science ®Google Scholar
• Brun-Buisson C, Legrand P, Rauss A, et al. Intestinal decontamination for control of nosocomial multiresistant Gram-negative bacilli: study of an outbreak in an intensive care unit. Ann Intern Med 1989; 110: 873–81
   PubMed Web of Science ®Google Scholar
• Spencer R C. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30(Suppl)453–64
   PubMedGoogle Scholar
• Bergogne-Berezin E, Joly-Guillou M L. Hospital infection with Acinetobacter spp.: an increasing problem. J Hosp Infect 1991; 18: 250–5
   PubMed Web of Science ®Google Scholar
• Bergogne-Berezin E. The increasing significance of outbreaks of Acinetobacter spp.: the needs for control and new agents. J Hosp Infect 1995; 30(Suppl)441–52
   PubMedGoogle Scholar
• Martinez-Martinez L, Pascual A, Tran J, Jacoby G A (1997) Plasmid-mediated resistance to quinolones (abstract). Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, Sept, 1996, 6–LB-20, 15–18
   Google Scholar
• Rasmussen B A, Bush K, Tally F P. Antimicrobial resistance in anaerobes. Clin Infect Dis 1997; 24(Suppl 1)SI10–20
   Google Scholar
• Sandven P, Bjorneklett A, Maeland A. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group. Antimicrob Agents Chemother 1993; 37: 2443–8
   PubMed Web of Science ®Google Scholar
• Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–6
   PubMed Web of Science ®Google Scholar
• Kollef M H, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 1040–8
   PubMed Web of Science ®Google Scholar
• Gould D. Nurses' hand decontamination practice: results of a local study. J Hosp Infect 1994; 28: 15–30
   PubMedGoogle Scholar
• Doebbeling B N, Stanley G L, Sheetz C T, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992; 327: 88–93
   PubMed Web of Science ®Google Scholar
• Albert R K, Condie F. Hand-washing patterns in medical intensive-care units. N Engl J Med 1981; 304: 1465–6
   PubMed Web of Science ®Google Scholar
• Simmons B, Bryant J, Neiman K, Spencer L, Arheart K. The role of handwashing in prevention of endemic intensive care unit infections. Infect Control Hosp Epidemiol 1990; 11: 589–94
   PubMedGoogle Scholar
• Jarvis W R. Handwashing - the Semmelweis lesson forgotten?. Lancet 1994; 344: 1311–2
   PubMed Web of Science ®Google Scholar